Characterization of Ex Vivo Expanded Tumor Infiltrating Lymphocytes from Patients with Malignant Melanoma for Clinical Application

Clinical trials of adoptive transfer of autologous tumor infiltrating lymphocytes (TILs) to patients with advanced malignant melanoma have shown remarkable results with objective clinical responses in 50% of the treated patients. In order to initiate a clinical trial in melanoma, we have established...

Descripción completa

Detalles Bibliográficos
Autores principales: Junker, Niels, thor Straten, Per, Andersen, Mads Hald, Svane, Inge Marie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2011
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3135163/
https://www.ncbi.nlm.nih.gov/pubmed/21773037
http://dx.doi.org/10.1155/2011/574695

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3135163/
https://www.ncbi.nlm.nih.gov/pubmed/21773037
http://dx.doi.org/10.1155/2011/574695

Ejemplares similares